GeneDx Holdings Corp. Capital Reinvestment Ratio
GeneDx Holdings Corp. capital reinvestment ratio. GeneDx Holdings Corp. (WGS) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow ($15.77 Million) in capital expenditures ($6.17 Million). See GeneDx Holdings Corp. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GeneDx Holdings Corp. (2025–2025)
Capital reinvestment ratio of GeneDx Holdings Corp. from 2025 to 2025. This chart tracks GeneDx Holdings Corp.'s Capital Reinvestment Ratio across 1 annual periods. See WGS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
GeneDx Holdings Corp. Capital Reinvestment Ratio by Year (2025–2025)
GeneDx Holdings Corp. capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see GeneDx Holdings Corp. (WGS) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | $33.28 Million | $19.02 Million | — |